Straits Times Index
3,061.35-15.09(-0.49%)S&P 500
4,455.48+6.50(+0.15%)Dow
34,798.00+33.20(+0.10%)Nasdaq
15,047.70-4.50(-0.03%)BTC-USD
43,186.15+492.23(+1.15%)CMC Crypto 200
1,067.20-35.86(-3.25%)
Kadmon Holdings, Inc. (KDMN)
| Previous close | 8.89 |
| Open | 8.86 |
| Bid | 8.82 x 1200 |
| Ask | 8.94 x 1200 |
| Day's range | 8.77 - 8.90 |
| 52-week range | 3.14 - 9.20 |
| Volume | 3,523,557 |
| Avg. volume | 7,938,376 |
| Market cap | 1.531B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.66 |
| Earnings date | 03 Nov 2021 - 08 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.10 |
- Business Wire
KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN
NEW ORLEANS, September 10, 2021--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Kadmon Holdings, Inc. (NasdaqGS: KDMN) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Kadmon will receive only $9.50 in cash for each share of Kadmon that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whet
- Zacks
Pharma Stock Roundup: SNY to Buy Kadmon, New Approvals for AZN & MRK's Drugs
Sanofi (SNY) offers $1.9 billion to buy Kadmon Holdings to strengthen its transplant business. AstraZeneca's (AZN) Ultomiris and Merck's (MRK) Keytruda get approvals for expanded use.
- Business Wire
Kadmon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Kadmon Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – KDMN
NEW YORK, September 09, 2021--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Kadmon Holdings, Inc. (NASDAQ: KDMN) to Sanofi for $9.50 per share in cash is fair to Kadmon shareholders.
